The use of scintigraphic imaging during liposome drug development

B. A. Goins, W. T. Phillips

Resultado de la investigación: Review articlerevisión exhaustiva

2 Citas (Scopus)


Liposomes, spherical lipid bilayers enclosing an aqueous space, have become an important class of drug carriers. This review describes the usefulness of scintigraphic imaging during the development of liposome-based drugs. This imaging modality is particularly helpful for tracking the distribution of liposomes in the body, monitoring the therapeutic responses following administration of liposome-based drugs, and investigating the physiological responses associated with liposome administration. Scintigraphy also can be used to monitor the therapeutic responses of patients given approved liposomal drugs. Several examples describing the potential of this imaging modality during both the preclinical formulation and clinical trial stages of liposomal drug development are included. Techniques for radiolabeling liposomes as well as methods for producing scintigraphic images are also described.

Idioma originalEnglish (US)
Páginas (desde-hasta)397-406
Número de páginas10
PublicaciónJournal of Pharmacy Practice
EstadoPublished - 2001

ASJC Scopus subject areas

  • Pharmacology (medical)


Profundice en los temas de investigación de 'The use of scintigraphic imaging during liposome drug development'. En conjunto forman una huella única.

Citar esto